• Sat. Apr 27th, 2024

HIV

  • Home
  • Zimbabwe Becomes First Country In Africa To Approve HIV Prevention Drug

Zimbabwe Becomes First Country In Africa To Approve HIV Prevention Drug

Zimbabwe has become the first county in Africa to approve a long-acting injectable drug that prevents HIV transmission. According to reports the first two injections of Cabotegraviror CAB-LA are administered…

Taraba State Begins Mass testing, As 77 Confirms HIV Positive

Taraba State Government has embarked on mass testing for the Human Immunodeficiency Virus, HIV. This was disclosed by the Taraba AIDS Control Agency (TACA) during a weekly review meeting held…

HIV: TACA Engages LACA Officers, Vaccine Managers

Taraba AIDS Control Agency (TACA) has held a one-day engagement meeting with Local Government AIDS Control Agency Coordinators and Local Government Covid-19 Vaccination Managers The meeting, held at the Star…

President Buhari Launches N62.1bn HIV Trust Fund

President Muhammadu Buhari has launched a N62.1 billion fund to improve efforts towards sustaining the country’s HIV response, addressing killer diseases, and public health emergencies. The trust fund was launched…

Namibia Partner Nigeria In The Fight Against HIV/AIDS

Namibia has expressed interest to partner Nigeria to effectively tackle HIV and AIDS in the Country. Namibia’s High commissioner to Nigeria, Mr. Humphrey Geiseb made this known when he paid…

NACA Launches Strategy To Reduce Dependence On Foreign Donors

National Agency for the Control of AIDS, NACA, has launched National Domestic Resource Mobilisation and Sustainability Strategy (2021-2025) to reduce over-dependence on international donors to fund HIV/AIDS interventions, responses and…

NACA Empowers 180 People Living with HIV In Jigawa

From USMAN MZ, Jigawa State. The National Agency for the Control of AIDS NACA has empowered 180 people living with HIV/AIDS in Jigawa state on six income generating trades in…

UN Welcomes New Therapy To Prevent HIV In Women

United Nations Programme on HIV/AIDS (UNAIDS) says the new anti-retroviral therapy cabotegravir could be a “game-changer” as a study shows it is many times more effective in preventing HIV in…